Peters, S. Pujol, J-L Dafni, U. Domine, M. Popat, S. and Reck, M. Andrade, J. Becker, A. Moro-Sibilot, D. and Curioni-Fontecedro, A. Molinier, O. Nackaerts, K. Molla, A. Insa Gervais, R. Lopez Vivanco, G. Madelaine, J. and Mazieres, J. Faehling, M. Griesinger, F. Majem, M. and Gonzalez Larriba, J. L. Provencio Pulla, M. Vervita, K. and Roschitzki-Voser, H. Ruepp, B. Mitchell, P. Stahel, R. A. and Le Pechoux, C. De Ruysscher, D. ETOP IFCT 4-12 STIMULI Collaborato, Consolidation nivolumab and ipilimumab versus observation in
limited-disease small-cell lung cancer after chemo-radiotherapy -
results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial, Annals of Oncology, (33), 67-79, 2022, Elsevier, 0923-7534, 1569-8041